Detalhe da pesquisa
1.
Tumor characteristics and prognosis in familial breast cancer.
BMC Cancer
; 16(1): 924, 2016 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27899083
2.
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial.
Ann Oncol
; 26(4): 675-682, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488686
3.
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI).
ESMO Open
; 6(2): 100054, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33601296
4.
Ovarian metastasis following gallbladder carcinoma: a case report.
Eur J Gynaecol Oncol
; 31(2): 219-21, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20527247
5.
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study.
Eur J Surg Oncol
; 44(6): 766-770, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29576462
6.
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054].
ESMO Open
; 6(2): 100097, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33926709
7.
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.
J Clin Oncol
; 14(10): 2702-8, 1996 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-8874330
8.
Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension.
Hypertension
; 7(2): 204-10, 1985.
Artigo
em Inglês
| MEDLINE | ID: mdl-2984117
9.
Low-dose dopamine induces early recovery of recombinant interleukin-2--impaired renal function.
Eur J Cancer
; 29A(8): 1119-22, 1993.
Artigo
em Inglês
| MEDLINE | ID: mdl-8518023
10.
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes?
Eur J Cancer
; 32A(1): 41-6, 1996 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-8695239
11.
Adjuvant chemoendocrine therapy for early breast-cancer - is it worthwhile - (review).
Int J Oncol
; 7(5): 1129-37, 1995 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21552942
12.
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.
Int J Oncol
; 15(2): 339-46, 1999 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-10402245
13.
Tailored therapy for aggressive non-Hodgkin's lymphoma: results of a phase II study with a long-term follow-up.
Int J Oncol
; 13(1): 121-7, 1998 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-9625813
14.
Phase I study of carboplatin, cisplatin, and cyclophosphamide without and with lenograstim for the treatment of ovarian cancer.
Int J Oncol
; 11(1): 175-80, 1997 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21528198
15.
Chlorambucil, vincristine and cytarabine (COA) treatment of low grade lymphomas.
Leuk Lymphoma
; 17(1-2): 147-53, 1995 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-7773152
16.
Maintenance therapy with recombinant interferon alpha-2B (alpha IFN) in prognostically unfavourable aggressive non-Hodgkin's lymphomas (NHL).
Oncol Rep
; 3(4): 733-5, 1996 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21594444
17.
Prognostic-significance of multifocality in primary breast-cancer.
Oncol Rep
; 1(6): 1045-8, 1994 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21607488
18.
Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancer.
Anticancer Res
; 20(5C): 4023-9, 2000.
Artigo
em Inglês
| MEDLINE | ID: mdl-11268496
19.
Intensive alternating combination chemotherapy and high dose chest radiotherapy in small cell lung cancer.
Tumori
; 77(5): 437-41, 1991 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-1664155
20.
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy.
Tumori
; 77(6): 506-10, 1991 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-1666468